| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase | 8363 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8371 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8373 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8376 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8385 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8399 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8404 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8350 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8356 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8382 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8394 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8396 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8359 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8367 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8372 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8375 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8383 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8384 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8395 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8400 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8402 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8355 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8362 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8364 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8366 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8381 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8388 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8401 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8408 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8409 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8410 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
Return to study ST001059 main page
Download data matrix(Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South Africa (part-II) Reversed phase)
- Metabolomics Workbench
|